Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1029-1042
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1029
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1029
Ref. | Study design | Total n | ICG group | Non-ICG group | Anastomosis leak n (%) | P value | Surgical plan change (%) |
Colorectal | |||||||
Kudszus et al[22], 2010 | Retrospective-matched | 402 | 201 | 201 | ICG: 7 (3.5%); NICG: 15 (7.5%) | 0.04 | 16% |
Jafari et al[23], 2013 | Case-control | 38 | 16 | 22 | ICG: 1 (6%); NICG: 4 (18%) | NS | 19% cases4.5% controls |
Kim et al[55], 2015 | Case-control | 436 | 123 | 313 | ICG: 1 (0.8%); NICG: 17 (5.4%) | NS | Not reported |
De Nardi et al[25], 2020 | Randomized controlled trial | 240 | 118 | 122 | ICG: 6 (5%); NICG: 11 (9%) | NS | 11% |
Alekseev et al[26], 2020 | Randomized controlled trial | 377 | 187 | 190 | ICG: 17 (9.1%); NICG: 31 (16.3%) | 0.04 | Not reported |
Arezzo et al[27], 2020 | Meta-analysis | 1330 | 862 | 468 | ICG: 36 (4.2%); NICG: 53 (11.3%) | < 0.001 | 11.3% |
Esophageal | |||||||
Zehetner et al[43], 2015 | Prospective | 150 | 150 | N/A | 4.6% | N/A | 66% |
Kumagai et al[47], 2018 | Cohort series | 70 | 70 | N/A | 1.4% | N/A | 50% |
Ladak et al[45], 2019 | Meta-analysis | 1067 | 631 | 436 | Overall: 10.8%; ICG: 5.7%; NICG: 22.9% | NR | Not reported |
Slooter et al[48], 2020 | Cohort series | 84 | 84 | N/A | 14.3% | N/A | 2.4% |
Ref. | Patients | Detection rate | Sensitivity | Specificity | Considerations |
Kusano et al[76], 2008 | 26 CRC, 22 GC | CRC: 90.9%, GC: 88% | CRC: S: 25%1, GS: 40%1 | Sp: 100%1, Sp: 100%1 | CRC: PPV: 100% NPV: 81%, GC: PPV: 100% NPV: 62.5% |
Cahill et al[78], 2009 | 891 | NR | 81% | 93.2%1 | PPV: 62% NPV: 95%. Lower FN if tumor size is less than 35 mm. IHC analysis increases sensitivity |
Noura et al[58], 2010 | 25 | 92% | 100% | 100% | FNR: 0%. NPV: 100% Performed lateral pelvic dissection in order to increase SN detection accuracy |
Kitagawa et al[80], 2013 | 397 | 97.5% | 93.44%1 | 98.99%1 | Uses dual technique (blue dye and ICG) |
Kinami et al[82], 2015 | 72 | 90% | 98%1 | FN: 1.3% | |
Tummers et al[79], 2016 | 26 | 95% | 75% | 88.9% | Reduces second-tier nodes using nanocolloids |
Lee et al[83], 2016 | 20 | 95% | 100% | 94.4% | FN: 0% |
Villegas-Tovar et al[57], 2020 | 281 | 91% | 64.3% | 65% | AUC: 66.5% |
Ref. | Yr | Patients | Nodules | Additional nodules | Sensitivity | Specificity | Considerations |
Liberale et al[95], 2020 | 2016 | 14 | 63 | 21.4% | 87.5% | 100% | |
Barabino et al[96], 2020 | 2016 | 10 | 88 | 72.4% | 77.3% | ||
Filippello et al[97], 2020 | 2016 | 10 | 29 | 65% | 57.1% | Same patients than Barabino et al[96], but comparing the use of bevacizumab or not | |
Lieto et al[100], 2020 | 2018 | 4 | 69 | 16 | 96.9% | 75% | ICG adds 25% of diagnostic improvement |
Sluiter et al[104], 2020 | 2019 | 28 | 169 | 80% | 74.8% | NBI increases sensitivity from 80% to 96% when compared with white light, with the same specificity |
- Citation: Martínez-López E, Martínez-Pérez A, Navarro-Martínez S, Sebastián-Tomás JC, de'Angelis N, García-Granero E. Real-time fluorescence image-guided gastrointestinal oncologic surgery: Towards a new era. World J Gastrointest Oncol 2021; 13(9): 1029-1042
- URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1029.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1029